نتائج البحث

Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease

• Authors : Ju-Young Hong; Keun-Young Park; Jong-Dai Kim

Subjects: sodium-glucose transporter 2 inhibitors; body composition; pulse wave velocity

• Source: Journal of Obesity & Metabolic Syndrome, Vol 29, Iss 3, Pp 215-221 (2020)

تفاصيل العنوان

Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

• Authors : Ju-Young Hong; Keun-Young Park; Jong-Dai Kim

Subjects: Diseases of the endocrine glands. Clinical endocrinology; RC648-665

• Source: Journal of Obesity & Metabolic Syndrome, Vol 30, Iss 1, Pp 74-75 (2021)

تفاصيل العنوان

Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

• Authors : Bo Kyung Koo

Subjects: Diseases of the endocrine glands. Clinical endocrinology; RC648-665

• Source: Journal of Obesity & Metabolic Syndrome, Vol 30, Iss 1, Pp 72-73 (2021)

تفاصيل العنوان

Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).

• Authors : Hong JY; Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.; Park KY

• Source: Journal of obesity & metabolic syndrome [J Obes Metab Syndr] 2021 Mar 30; Vol. 30 (1), pp. 74-75.Publisher: Korean Society for the Study of Obesity Country of Publication: Korea (South) NLM ID: 101704724 Publication Model:

تفاصيل العنوان

Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).

• Authors : Koo BK; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

• Source: Journal of obesity & metabolic syndrome [J Obes Metab Syndr] 2021 Mar 30; Vol. 30 (1), pp. 72-73.Publisher: Korean Society for the Study of Obesity Country of Publication: Korea (South) NLM ID: 101704724 Publication Model:

تفاصيل العنوان

Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease.

• Authors : Hong JY; Division of Endocrinology, Department of Internal Medicine, College of Medicine, Konyang University, Daejeon, Korea.; Park KY

• Source: Journal of obesity & metabolic syndrome [J Obes Metab Syndr] 2020 Sep 30; Vol. 29 (3), pp. 215-221.Publisher: Korean Society for the Study of Obesity Country of Publication: Korea (South) NLM ID: 101704724 Publication Model:

تفاصيل العنوان

Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

• Authors : Dong-Mee Lim; Jong-Dai Kim; Won Min Hwang

Subjects: medicine.medical_specialty; lcsh:RC648-665; Atherosclerotic cardiovascular disease

• Source: Journal of Obesity & Metabolic SyndromeJournal of Obesity & Metabolic Syndrome, Vol 30, Iss 1, Pp 74-75 (2021)

تفاصيل العنوان